Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Change in Inventory of -$6.2 million for Q1 2026, down 120.08% year-over-year from $31.1 million in Q1 2025, and up 30.65% quarter-over-quarter from -$9.0 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Change in Inventory (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Change in Inventory history runs 14 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 120.08% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$16.3 million (down 123.31% YoY), while the FY2025 annual figure was $21.1 million, down 56.84% from the prior year.
- Change in Inventory for Q1 2026 stood at -$6.2 million, up from -$9.0 million in the prior quarter.
- The five-year high for Change in Inventory was $31.1 million in Q1 2025, with the low at -$9.0 million in Q4 2025.
- The 5-year median for Change in Inventory is $4.7 million (2022), against an average of $4.5 million.
- The sharpest annual moves came in 2023 and 2024: Change in Inventory slumped 309.27% in 2023, then soared 3829.48% in 2024.
- Amphastar Pharmaceuticals' Change in Inventory stood at -$1.2 million in 2022, then slumped by 309.27% to -$4.8 million in 2023, then jumped by 608.37% to $24.5 million in 2024, then tumbled by 136.82% to -$9.0 million in 2025, then jumped by 30.65% to -$6.2 million in 2026.
- Business Quant data shows AMPH's Change in Inventory at -$6.2 million in Q1 2026, -$9.0 million in Q4 2025, and -$5.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 937.87 Mn | 647.74 Mn | 93.47 Mn | 9.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.88 Mn |
| Jun 30, 2026 | 9.88 Mn |
| Mar 31, 2026 | -6.25 Mn |
| Mar 31, 2026 | -6.25 Mn |
| Dec 31, 2025 | -9.01 Mn |
| Dec 31, 2025 | -9.01 Mn |
| Sep 30, 2025 | -5.86 Mn |
| Sep 30, 2025 | -5.86 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | 4.82 Mn |
| Mar 31, 2025 | 31.11 Mn |
| Mar 31, 2025 | 31.11 Mn |
| Dec 31, 2024 | 24.47 Mn |
| Dec 31, 2024 | 24.47 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Sep 30, 2024 | 7.31 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |